Yosuke Nakano
About
Yosuke Nakano is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Yosuke Nakano has authored 38 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yosuke Nakano's work include Coronary Interventions and Diagnostics (14 papers), Cardiac Imaging and Diagnostics (11 papers) and Cardiac Valve Diseases and Treatments (10 papers). Yosuke Nakano is often cited by papers focused on Coronary Interventions and Diagnostics (14 papers), Cardiac Imaging and Diagnostics (11 papers) and Cardiac Valve Diseases and Treatments (10 papers). Yosuke Nakano collaborates with scholars based in Japan and United States. Yosuke Nakano's co-authors include Eiichiro Fukusaki, Ikutaro Hamada, Susumu Yanagisawa, Yoshitada Morikawa, Hiroshi Wada, Motoji Fujioka, Kenji Toyoda, Kyuho Lee, Tetsuya Ishikawa and Makoto Mutoh and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Chemistry - A European Journal.
In The Last Decade
Yosuke Nakano
37 papers receiving 509 citations
Peers
Yosuke Nakano
Satoshi Hirayama Japan
Junichi Kondo Japan
Hanan Elajaili United States
Peter Bast United States
Maria Chiara Mimmi Italy
Ruochuan Liu China
Kazuo Oikawa Japan
Maria Letizia Lo Faro United Kingdom
Sheng Pan China
Andrea Catte United States
Citations per year, relative to Yosuke Nakano Yosuke Nakano (= 1×)
peers
Satoshi Hirayama
Countries citing papers authored by Yosuke Nakano
Since
Specialization
Citations
This map shows the geographic impact of Yosuke Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Nakano more than expected).
Fields of papers citing papers by Yosuke Nakano
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yosuke Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Nakano. The network helps show where Yosuke Nakano may publish in the future.
Co-authorship network of co-authors of Yosuke Nakano
This figure shows the co-authorship network connecting the top 25 collaborators of Yosuke Nakano. A scholar is included among the top collaborators of Yosuke Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosuke Nakano. Yosuke Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Matsubara, Nobuaki, Takahiro Osawa, Takashige Abe, et al.. (2025). FGFR2/3 Gene Alterations and Clinical Outcomes in Advanced/Metastatic Urothelial Cancer in Japan: MONSTAR ‐SCREEN Database Study. Cancer Science. 116(5). 1424–1432.
2.
Nakano, Yosuke, et al.. (2019). High-Throughput LC-MS/MS Method for Chiral Amino Acid Analysis Without Derivatization. Methods in molecular biology. 2030. 253–261.
3.
Nakano, Yosuke, et al.. (2019). Automatic switching valve system to minimize variation of liquid chromatography-tandem mass spectrometry-based chiral amino acid profiling. Journal of Bioscience and Bioengineering. 128(6). 773–779.
4.
Nakano, Yosuke, et al.. (2018). High-sensitive liquid chromatography-tandem mass spectrometry-based chiral metabolic profiling focusing on amino acids and related metabolites. Journal of Bioscience and Bioengineering. 127(4). 520–527.
5.
Furuno, Masahiro, et al.. (2018). Mechanistic study on the high-selectivity enantioseparation of amino acids using a chiral crown ether-bonded stationary phase and acidic, highly organic mobile phase by liquid chromatography/time-of-flight mass spectrometry. Journal of Chromatography A. 1578. 35–44.
6.
Nakano, Yosuke, et al.. (2017). Investigation of storage time-dependent alterations of enantioselective amino acid profiles in kimchi using liquid chromatography-time of flight mass spectrometry. Journal of Bioscience and Bioengineering. 124(4). 414–418.
7.
Nakano, Yosuke, et al.. (2016). In vitro steroid profiling system for the evaluation of endocrine disruptors. Journal of Bioscience and Bioengineering. 122(3). 370–377.
8.
Miyamoto, Takashi, Tetsuya Ishikawa, Yosuke Nakano, & Makoto Mutoh. (2016). Very long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement for ST-elevation myocardial infarction: a propensity score-matched comparison. Cardiovascular Intervention and Therapeutics. 32(1). 24–35.
9.
Nakano, Yosuke, et al.. (2016). Development of a liquid chromatography-tandem mass spectrometry method for quantitative analysis of trace d-amino acids. Journal of Bioscience and Bioengineering. 123(1). 134–138.
10.
Nakano, Yosuke, Tetsuya Ishikawa, & Makoto Mutoh. (2015). Long-term angiographic outcomes of sirolimus- and paclitaxel-eluting stent placement in diabetes, long lesions, and small vessels. Cardiovascular Intervention and Therapeutics. 30(4). 327–337.
11.
Ishikawa, Tetsuya, et al.. (2014). Midterm outcomes of bare-metal stenting after primary stenting for ST-segment elevated myocardial infarctions in the drug-eluting stent era: a propensity score-matched comparison with sirolimus-eluting stent. Cardiovascular Intervention and Therapeutics. 30(3). 234–243.
12.
Ishikawa, Tetsuya, et al.. (2014). Long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement following rotablation for severely calcified lesions: a retrospective nonrandomized study. Cardiovascular Intervention and Therapeutics. 30(1). 29–37.
13.
Ishikawa, Tetsuya, et al.. (2014). Propensity Score-matched Lesion-based Comparison of Mid-term Angiographic Outcomes of TAXUS Liberté with Cypher Bx Velocity Stents for <i>De Novo</i> Native Coronary Stenosis and in Patients with Diabetes. Internal Medicine. 53(12). 1265–1273.
14.
Ishikawa, Tetsuya, et al.. (2013). Propensity-matched lesion-based comparison of midterm outcomes of TAXUS Express and TAXUS Liberté stents for de novo native coronary stenosis. Journal of Cardiology. 62(5). 289–295.
15.
Ishikawa, Tetsuya, et al.. (2012). Post-discharge clinical and angiographic outcomes of patients presenting within 48 h of STEMI treated with paclitaxel- or sirolimus-eluting stents. Journal of Cardiology. 60(3). 174–179.
16.
Ishikawa, Tetsuya, Makoto Mutoh, Yosuke Nakano, et al.. (2010). Retrospective comparison of clinical and angiographic outcomes after primary stenting using sirolimus-eluting and bare-metal stents in nonrandomized consecutive 568 patients with first ST-segment elevated myocardial infarctions. Journal of Cardiology. 57(1). 44–52.
17.
Ishikawa, Tetsuya, Yosuke Nakano, Akira Endoh, et al.. (2009). Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: A retrospective comparison with western mega-studies. Journal of Cardiology. 54(2). 238–244.
18.
Toyoda, Kenji, Yosuke Nakano, Ikutaro Hamada, et al.. (2009). First-principles study of the pentacene/Cu(111) interface: Adsorption states and vacuum level shifts. Journal of Electron Spectroscopy and Related Phenomena. 174(1-3). 78–84.
19.
Fujita, Masahide, Taisuke Ishii, Yasuo Tsukahara, et al.. (1989). ESTABLISHMENT OF THE OPTIMUM CONDITIONS FOR INDUCTION OF STOMACH CARCINOMA IN RATS BY CONTINUOUS ORAL ADMINISTRATION OF N-METHYL-N-NITROSOUREA. Journal of Toxicologic Pathology. 2(1). 27–32.
20.
Fujita, Masahide, Yosuke Nakano, Jun Ohta, & T Taguchi. (1986). Mass screening for colorectal cancer by testing fecal occult blood. Cancer. 57(11). 2241–2245.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Satoshi Hirayama Breakdown of academic impact, for papers by Junichi Kondo Breakdown of academic impact, for papers by Hanan Elajaili Breakdown of academic impact, for papers by Peter Bast Breakdown of academic impact, for papers by Maria Chiara Mimmi Breakdown of academic impact, for papers by Ruochuan Liu Breakdown of academic impact, for papers by Kazuo Oikawa Breakdown of academic impact, for papers by Maria Letizia Lo Faro Breakdown of academic impact, for papers by Sheng Pan Breakdown of academic impact, for papers by Andrea Catte